ÐÇ¿Õ´«Ã½

Skip to main content

Gout drug colchicine doesn't reduce risk of death in COVID-19 patients: analysis

Share
North Bay -

A new analysis of the gout drug colchicine has found no evidence that it lessens the severity of COVID-19 or cuts the risk of death from infection in hospitalized patients.

In turn, the analysis found the drug is associated with a high risk of side effects, namely diarrhea.

The analysis, published in the , looked at available evidence for the use of colchicine, a cheap anti-inflammatory drug normally used to treat gout, to treat COVID-19.

Early observational studies had suggested colchicine may be a useful addition to available COVID-19 treatments, a news release said Monday. The researchers looked through research databases for relevant comparative clinical trial data on the use of the drug for the treatment of COVID-19 published up to July 2021 to clarify its safety and effectiveness.

"Colchicine does not reduce the risk of mortality, need for ventilatory support, intensive care unit admission or length of hospital stay among patients with COVID-19. There is no additional benefit of adding colchicine to supportive care in the management of patients with COVID-19," the researchers concluded.

Six studies found no significant reduction in the risk of death between patients treated with colchicine and those given usual supportive care only. As well, no significant reductions were found in the need for ventilatory support (five studies), admission to intensive care (three studies), length of hospital stay (four studies) or serious side effects (three studies).

The researchers found patients taking colchicine also had a 58 per cent higher rate of side effects and nearly double the risk of diarrhea than those given supportive care.

They said their findings should be interpreted cautiously due to the inclusion of open labelled randomized clinical trials — an open label study is when both the researcher and participant know the drug or treatment being given. As well, they say their analysis was based on a small number of randomized controlled trials in control interventions.

Observational studies, laboratory studies, animal studies and studies with fewer than 10 participants were all excluded. Out of 69 full texts, six randomized controlled trials involving 16,148 patients with varying degrees of severity of COVID-19 were included in the analysis.

In March 2020, during the early months of the COVID-19 pandemic, a team of Canadian researchers, led by director of the Montreal Heart Institute (MHI) Jean-Claude Tardif, announced it had launched a study into the use of colchicine to reduce the risks of pulmonary complications and death related to the coronavirus.

In January 2021, the MHI announced that clinical trials had shown "persuasive results" of the efficacy of colchicine to treat COVID-19, calling it a

However, reported that many scientists have as overstating the benefits of colchicine.

The results were later published in . A statement released in May by the MHI said the article concluded that "given the lack of oral therapies available to prevent COVID-19 complications among non-hospitalized patients and the observed benefit of colchicine in patients with a PCR-confirmed diagnosis of COVID-19, this anti-inflammatory drug could be considered as a treatment for those at risk of complications."

CTVNews.ca ÐÇ¿Õ´«Ã½

BREAKING

BREAKING

Three men were injured after a man armed with a knife entered a Montreal-area Islamic cultural centre Friday afternoon.

A 15-year-old boy who was the subject of an emergency alert in New Brunswick has been arrested.

Police have arrested an 18-year-old woman who allegedly stole a Porche and then ran over its owner in an incident that was captured on video.

Since she was a young girl growing up in Vancouver, Ginny Lam says her mom Yat Hei Law made it very clear she favoured her son William, because he was her male heir.

The parents of a teenager who died after allegedly consuming the poisonous products of a Mississauga man are now suing him, as well as several doctors involved in her care.

The search for a missing six-year-old boy in Shamattawa is continuing Friday as RCMP hope recent tips can help lead to a happy conclusion.

Local Spotlight

Getting a photograph of a rainbow? Common. Getting a photo of a lightning strike? Rare. Getting a photo of both at the same time? Extremely rare, but it happened to a Manitoba photographer this week.

They say a dog is a man’s best friend. In the case of Darren Cropper, from Bonfield, Ont., his three-year-old Siberian husky and golden retriever mix named Bear literally saved his life.

A growing group of brides and wedding photographers from across the province say they have been taken for tens of thousands of dollars by a Barrie, Ont. wedding photographer.

Paleontologists from the Royal B.C. Museum have uncovered "a trove of extraordinary fossils" high in the mountains of northern B.C., the museum announced Thursday.

The search for a missing ancient 28-year-old chocolate donkey ended with a tragic discovery Wednesday.

The Royal Canadian Mounted Police is celebrating an important milestone in the organization's history: 50 years since the first women joined the force.

It's been a whirlwind of joyful events for a northern Ontario couple who just welcomed a baby into their family and won the $70 million Lotto Max jackpot last month.

A Good Samaritan in New Brunswick has replaced a man's stolen bottle cart so he can continue to collect cans and bottles in his Moncton neighbourhood.

David Krumholtz, known for roles like Bernard the Elf in The Santa Clause and physicist Isidor Rabi in Oppenheimer, has spent the latter part of his summer filming horror flick Altar in Winnipeg. He says Winnipeg is the most movie-savvy town he's ever been in.

Stay Connected